Literature DB >> 26241378

Design and Characterization of Chemically Stabilized Aβ42 Oligomers.

Ghiam Yamin1,2, Tien-Phat Vuong Huynh3, David B Teplow2.   

Abstract

A popular working hypothesis of Alzheimer's disease causation is amyloid β-protein oligomers are the key neuropathogenetic agents. Rigorously elucidating the role of oligomers requires the production of stable oligomers of each size. We previously used zero-length photochemical cross-linking to allow stabilization, isolation, and determination of structure-activity relationships of pure populations of Aβ40 dimers, trimers, and tetramers. We also attempted to study Aβ42 but found that Aβ42 oligomers subjected to the same procedures were not completely stable. On the basis of the fact that Tyr is a critical residue in cross-linking chemistry, we reasoned that the chemical accessibility of Tyr10 in Aβ42 must differ from that in Aβ40. We thus chemically synthesized four singly substituted Tyr variants that placed the Tyr in different positions across the Aβ42 sequence. We then studied the stability of the resulting cross-linked oligomers as well as procedures for fractionating the oligomers to obtain pure populations of different sizes. We found that [Phe(10),Tyr(42)]Aβ42 produced stable oligomers yielding highly pure populations of dimers through heptamers. This provides the means to establish formal structure-activity relationships of these important Aβ42 assemblies. In addition, we were able to analyze the dissociation patterns of non-cross-linked oligomers to produce a model for oligomer formation. This work is relevant to the determination of structure-activity relationships that have the potential to provide mechanistic insights into disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26241378      PMCID: PMC5104494          DOI: 10.1021/acs.biochem.5b00318

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence.

Authors:  Samir K Maji; Jason J Amsden; Kenneth J Rothschild; Margaret M Condron; David B Teplow
Journal:  Biochemistry       Date:  2005-10-11       Impact factor: 3.162

3.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

4.  Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-β.

Authors:  Toshihiko Sugiki; Naoko Utsunomiya-Tate
Journal:  Biochem Biophys Res Commun       Date:  2013-11-15       Impact factor: 3.575

5.  Amino acid position-specific contributions to amyloid beta-protein oligomerization.

Authors:  Samir K Maji; Rachel R Ogorzalek Loo; Mohammed Inayathullah; Sean M Spring; Sabrina S Vollers; Margaret M Condron; Gal Bitan; Joseph A Loo; David B Teplow
Journal:  J Biol Chem       Date:  2009-06-30       Impact factor: 5.157

6.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

7.  Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.

Authors:  Summer L Bernstein; Nicholas F Dupuis; Noel D Lazo; Thomas Wyttenbach; Margaret M Condron; Gal Bitan; David B Teplow; Joan-Emma Shea; Brandon T Ruotolo; Carol V Robinson; Michael T Bowers
Journal:  Nat Chem       Date:  2009-07       Impact factor: 24.427

8.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

9.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

Authors:  A Y Hsia; E Masliah; L McConlogue; G Q Yu; G Tatsuno; K Hu; D Kholodenko; R C Malenka; R A Nicoll; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

10.  Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization.

Authors:  Gal Bitan; Sabrina S Vollers; David B Teplow
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

View more
  5 in total

1.  Preparation of pure populations of covalently stabilized amyloid β-protein oligomers of specific sizes.

Authors:  Eric Y Hayden; Joseph L Conovaloff; Ashley Mason; Gal Bitan; David B Teplow
Journal:  Anal Biochem       Date:  2016-10-31       Impact factor: 3.365

2.  Nanoscale Dynamics of Amyloid β-42 Oligomers As Revealed by High-Speed Atomic Force Microscopy.

Authors:  Siddhartha Banerjee; Zhiqiang Sun; Eric Y Hayden; David B Teplow; Yuri L Lyubchenko
Journal:  ACS Nano       Date:  2017-11-29       Impact factor: 15.881

3.  Visualizing and trapping transient oligomers in amyloid assembly pathways.

Authors:  Emma E Cawood; Theodoros K Karamanos; Andrew J Wilson; Sheena E Radford
Journal:  Biophys Chem       Date:  2020-11-10       Impact factor: 2.352

4.  A novel pathway for amyloids self-assembly in aggregates at nanomolar concentration mediated by the interaction with surfaces.

Authors:  Siddhartha Banerjee; Mohtadin Hashemi; Zhengjian Lv; Sibaprasad Maity; Jean-Christophe Rochet; Yuri L Lyubchenko
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

5.  Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis.

Authors:  Kazuma Murakami; Maki Tokuda; Takashi Suzuki; Yumi Irie; Mizuho Hanaki; Naotaka Izuo; Yoko Monobe; Ken-Ichi Akagi; Ryotaro Ishii; Harutsugu Tatebe; Takahiko Tokuda; Masahiro Maeda; Toshiaki Kume; Takahiko Shimizu; Kazuhiro Irie
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.